Margasa, Baby Boy .
HRN: 24-90-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2024
AMPICILLIN 500MG (VIAL)
04/28/2024
05/04/2024
IV
155mg
Q12h
Potentially Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes